Science & Enterprise subscription

Follow us on Twitter

  • National Science Foundation is funding a new system that uses artificial intelligence to find optimal combinations… https://t.co/jbZAJqQpmT
    about 3 hours ago
  • New post on Science and Enterprise: NSF Funds AI Covid-19 Drug Combo Simulation https://t.co/j7DsIncCUk #Science #Business
    about 3 hours ago
  • A spin-off enterprise from academic labs is raising $125 million for genetically edited pigs to produce organs for… https://t.co/CVwEr6dEoU
    about 3 hours ago
  • New post on Science and Enterprise: Gene-Edited Transplant Organ Company Raises $125M https://t.co/UYlUcA8Z5X #Science #Business
    about 7 hours ago
  • A home Covid-19 test is being evaluated with a smartphone app, as part of an NIH program to quickly develop Covid-1… https://t.co/82gYsU3rvr
    about 1 day ago

Please share Science & Enterprise

Photo Algorithms Find Cancerous Melanoma Lesions

Phone photo

An engineering team designed artificial intelligence techniques with image analysis to identify early signs of skin cancer in ordinary photographs. . . . → Read More: Photo Algorithms Find Cancerous Melanoma Lesions

AbbVie Licenses Engineered Crispr Cell Process

Drug maker AbbVie is acquiring a technology using the gene-editing process Crispr to produce new off-the-shelf engineered T-cells as disease therapies. . . . → Read More: AbbVie Licenses Engineered Crispr Cell Process

Cannabidiol Drug Maker Acquired in $7.2B Deal

Cannabis plant

A developer of treatments for rare neurological diseases derived from cannabis is being acquired by Jazz Pharmaceuticals in a $7.2 billion deal. . . . → Read More: Cannabidiol Drug Maker Acquired in $7.2B Deal

Trial Testing Ultrasound Treatment for Liver Cancer

Liver

A clinical trial is underway assessing the safety of an experimental non-invasive ultrasound therapy to treat liver cancer. . . . → Read More: Trial Testing Ultrasound Treatment for Liver Cancer

Cancer Immunotherapy Adapted for HIV

T-cell infected by HIV

A biotechnology company is adapting and licensing its immunotherapy process, originally designed for cancer, as a cure for HIV infections. . . . → Read More: Cancer Immunotherapy Adapted for HIV

Multi-Variant Covid-19 Vaccine in the Works

SARS-CoV-2 and cell

A vaccine protecting against multiple Covid-19 viral variations is in development, with an early-stage clinical trial expected to begin soon. . . . → Read More: Multi-Variant Covid-19 Vaccine in the Works

Drug Maker Gains Access to Hidden Protein Immunotherapies

T-cells and cancer cells

Global drug maker Boehringer Ingelheim is gaining access to an immunotherapy technology that targets usually hidden proteins to attack cancer cells. . . . → Read More: Drug Maker Gains Access to Hidden Protein Immunotherapies

Drug Price Disruptor Biotech Raises $500M in New Funds

Pills and dollar bill

A start-up biotechnology company that aims to bring drugs to market at lower cost is raising $500 million in its second venture funding round. . . . → Read More: Drug Price Disruptor Biotech Raises $500M in New Funds

Digital Therapeutics Designed for Cancer/Covid-19 Stress

Man with depression

A digital health company is partnering with cancer advocacy organizations to provide electronic therapies to help patients deal with stresses from Covid-19. . . . → Read More: Digital Therapeutics Designed for Cancer/Covid-19 Stress

Synthetic Biology Company Raises $105M in New Funds

DNA chip graphic

A company developing cellular and genetic therapies for cancer designed like electronic circuits is raising $105 million in its second venture round. . . . → Read More: Synthetic Biology Company Raises $105M in New Funds